Australia's largest stock trading and investment forum Australia's #1 stock forum

DXB

Click for more information

3.33%

43.5¢ dimerix limited

Ann: DMX-200 Competitive Position Further Enhanced, page-61

First 61 Last

Share
Profile

Follow
HS2912

47 Posts.

11

26/03/21

07:16

Post #: 52053216
Share

Originally posted by Owl vs Fox: ↑

GMP is required for all human clinical trials & manufacture of drugs! DXB already have upscaled GMP & FDA approved manufacturing of DMX-200 in the USA for COVID-19 trials via an approved Pharma for patient needs & not considering upcoming renal disease trials, you are potentially looking at dosing for 1000 patients, just to cover the initial 200 in REMAP CAP & move to Ph3, then 600 in CLARITY-2.0, and then all the patients that remain on Special Access Scheme via scripts from their treating Physicians (coming up to>4 years now for some patients from Ph2A, these ones were sicker, you are looking at a potential diversion from dialysis right here. The FDA requirements for approval were started way back in 2019 for packaging, shelf life stability, all those things required were done prior to Ph2. TGA obviously happy with SAS earlier on & not many drugs are given the ok this way, there has to be very good evidence. That data is sitting there now for PH3 & open label.

Not sure what you are talking about @HS2912??

GLTAH

Expand

This is an in vitro study, hence no requirements. Obviously different story if it was in humans...

DXB Price at posting: 26.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

SKS

SKS secures $20M for extension works on Melbourne data centre

BOE

Boss Energy ramps up as industrial-scale plant build continues; FY25 guidance of 850Klb intact

GDP grows 0.2% in June quarter, but annual growth the slowest since the 1990s

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

EBR

EBR Systems' heart pacing device on-target to reach the US market

There are more pages in this discussion • 6 more messages in this thread...

First 61 Last

Add DXB (ASX) to my watchlist

(20min delay)
Last 43.5¢		Change -0.015(3.33%)		Mkt cap ! $239.5M

Open	High	Low	Value	Volume
43.5¢	43.8¢	42.0¢	$988.7K	2.301M

Buyers (Bids)

No.	Vol.	Price($)
1	10000	43.0¢

Sellers (Offers)

Price($)	Vol.	No.
43.5¢	17061	1

View Market Depth

No.	Vol.	Price($)
1	10000	0.430
4	162352	0.425
14	308110	0.420
8	226373	0.415
8	199251	0.410

Price($)	Vol.	No.
0.435	17061	1
0.440	17062	1
0.445	45000	2
0.450	218895	3
0.455	45000	1

Last trade - 16.10pm 04/09/2024 (20 minute delay)

DXB (ASX) Chart